Treating critically ill COVID-19 patients with a combination of lopinavir (LPV) and ritonavir (RTV) is associated with a significant risk of bradycardia, according to new research out of France.

The study, published in Circulation:…

The FDA has approved Abbott’s line of Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator solutions.

The devices offer numerous new features, including an improved battery, MRI…

Cloud-based cardiac imaging company inHeart has received $4.2 million in funding for its product that creates a 3D replicate image of a patient’s heart to assist in pre-procedural planning.

European venture capital firm Elaia led this…

A new study suggests COVID-19 has the potential to infect cardiac cells, causing changes in their ability to function after just 72 hours. 

The researchers found that SARS-CoV-2, the virus behind COVID-19, was capable of…

A higher rate of cardiac arrhythmias has been observed in hospitalized COVID-19 patients, but new research suggests there’s more behind that trend than the virus itself.

The study, published in Heart Rhythm Journal, explored…

Outpatient prescriptions for azithromycin are associated with an increased risk of cardiovascular mortality, according to new research published in JAMA Network Open.

The common antibiotic has long been associated with adverse…

Individuals with a history of cardiovascular disease are at a higher risk of contracting COVID-19, and a significant number of hospitalized patients end up requiring mechanical ventilation or oxygen.

There is some promising news for…

A cardiologist at the University of Chicago Medicine has performed the first cardioneural ablation in U.S. history, using it to “rewire” the heart of a patient suffering from vasovagal syncope. The patient had tried numerous treatments for the…

Treating atrial fibrillation (AF) patients with catheter ablation is associated with a decreased risk of mortality, heart failure admission and stroke, according to new findings…

Non-vitamin K antagonist oral anticoagulants (NOACs) are a valuable treatment option for atrial fibrillation (AF) patients with a prior intracranial hemorrhage (ICH), according to…

The association between COVID-19 and cardiac arrhythmias is significant, especially when patients are hit hard by the disease and moved to the ICU. A new analysis published in…

Hydroxychloroquine and azithromycin are both associated with significant cardiovascular complications, and taking them together could be a deadly combination, according to…

The survival rate for COVID-19 patients who require cardiopulmonary resuscitation for in-hospital cardiac arrest is just 2.9%, according to recent research out of Wuhan, China.

New findings published in Circulation: …

On Monday, May 18, President Donald Trump said he has been taking hydroxychloroquine to help prevent a COVID-19 infection.

Trump has been taking the antimalarial drug for more than a week, he said. The news came just weeks after the FDA…

The Society of Cardiovascular Angiography and Interventions (SCAI) has shared a new guidance detailing the management of patients with out-of-hospital cardiac arrest (OHCA).

The guidance,…

An AI algorithm could limit false-positive AFib episodes detected by implantable loop recorders (ILRs), according to new research presented during the…

Catheter ablation using a contact force (CF)-sensing catheter may be a safe, effective treatment option for patients with persistent AFib (PsAF), according to…

New research into the effectiveness of treating COVID-19 patients with hydroxychloroquine found no significant associations between the antimalarial drug and intubation or death.

The potential use of hydroxychloroquine to treat COVID-19…

In areas with limited resources, healthcare providers often receive medical devices that have been used and resterilized—but is there an added risk of infection with those devices?

Researchers studied data from 1,051 patients who…

Treating COVID-19 patients with hydroxychloroquine, alone or in combination with azithromycin, is associated with an increased risk of QTc prolongation, according to two new studies published in JAMA Cardiology.

The potential…

Novartis is launching a new clinical trial to assess the effectiveness of treating hospitalized COVID-19 patients with hydroxychloroquine. The FDA has official signed off on the trial, according to a statement from Novartis, and it will include…